Black tea consumption does not protect low density lipoprotein from oxidative modification

European Journal of Clinical Nutrition

Volumn 52, Issue 3, 1998, Pages 202-206

  McAnlis, G T ^a   McEneny, J ^a   Pearce, J ^a   Young, I S ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Antioxidants; Flavonoids; Low density lipoprotein (LDL); Tea

Indexed keywords

CHOLESTEROL; COPPER; FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; COFFEE; DIETARY INTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID OXIDATION; MALE; NORMAL HUMAN; TEA; TRIACYLGLYCEROL BLOOD LEVEL;

CAMELLIA SINENSIS;

EID: 0031885789     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600540     Document Type: Article

References (30)

1. Balentine DA (1992): Manufacturing and chemistry of tea. In Phenolic Compounds in Food and Their Effects of Health I, eds. H Chi-Tang, YL Chang & H Mou-Tuan, pp 102-117. Washington DC: ASC.
2. de-Whalley CV, Rankin SM, Hoult JRS, Jessup W & Leake DS (1990): Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharmacol. 39, 1743-1750.
3. Frankel EN, Kanner J, German JB, Parks E & Kinsella JE (1993): Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341, 454-457.
4. Fuhrman B, Lavy A & Aviram M (1995): Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am. Soc. Clin. Nutr. 61, 549-554.
5. Goldstein JL, Ho YK, Basu SK & Brown MS (1979): Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. 76, 333-337.
6. He YH & Kies C (1993): Green and black tea consumption by humans: Impact on polyphenol concentration in feces, blood and urine. Plant Foods Hum. Nutr 46, 221-229.
7. Hertog MGL, Hollman PCH & Katan MB (1992): Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J. Agric. Food Chem. 40, 2379-2383.
8. Hertog MGL, Hollman PCH & Putte B (1993a): Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J. Agric. Food Chem. 41, 1242-1246.
9. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB & Kromhout D (1993b): Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342, 1007-1011.
10. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH, Katan MB (1995): Flavonoid intake and long-term risk of coronary heart-disease and cancer in the 7 countries study. Archives of Internal Medicine 155, 381-386.
11. Hertog MGL, Sweetnam PM, Fehily AM, Elwood PC & Kromhout D (1997): Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am. J. Clin. Nutr. 65, 1489-1494.
12. Igarashi K & Ohmuma M (1995): Effect of isohamneti, rhamnetin, and quercetin on the concentrations of cholesterol and lipoperoxide in the serum and liver and on the blood and liver antioxidative enzyme activities in rats. Biosci. Biotech. Biochem. 59: 595-601.
13. Keli SO, Hertog MGL, Feskens EJM & Kromhout D (1996): Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch. Int. Med. 156, 637-642.
14. Knekt P, Jarvinen R, Reunanen A & Maatela J (1996): Flavonoid intake and coronary mortality in Finland: a cohort study. Br. Med. J. 312, 478-481.
15. Kuhnau J (1979b): The Flavonoids: A class of semi-essential food components; their role in human nutrition. World Rev. Nutr. Diet 24 117-191.
16. Laughton MJ, Evans PJ, Moroney MA, Hoult JRS & Halliwell B (1991): Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Biochem. Pharmacol. 42, 1673-1681.
17. Lee MJ, Wang ZY, Li H, Sun Y, Gobbo S, Balentine DA & Yang CS (1995): Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers and Prevention 4, 393-399.
18. McAnlis GT, McEneny J, Pearce J & Young IY (1997): Quercetin levels in plasma after fried onion breakfast. Proc. Nutr. Soc. In press.
19. McAnlis GT, McEneny J, Pearce J & Young IY (1997): The effect of various dietary flavonoids on the susceptibility of low density lipoproteins to oxidation in vitro using both metallic and non-metallic oxidising agents. Biochem. Soc. Trans. 25, 142S.
20. McDowell IFW, McEneny J & Trimble ER (1995): A rapid method for measurement of the susceptibility to oxidation of LDL. Clin. Biochem. 32, 167-174.
21. Morel I, Lescoat G, Cogrel P & Cillard J (1993): Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol. 45, 13-19.
22. Muramatsu K, Fukuyo M & Hara Y (1986): Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 32, 613-622.
23. Negre-Salvayre A, Alomar Y, Troly M & Salvayre R (1991): UV treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidised LDL occurs in two different ways. Biochim. Biophys. Acta 1096, 291-300.
24. Rankin SM, de-Whalley CV, Hoult JRS, Jessup W, Wilkins GM, Collard J & Leake DS (1993): The modification of low density lipoprotein by the flavonoids myricetin and gossypetin. Biochem. Pharmacol. 45, 67-75.
25. Rice-Evans CA, Miller NJ & Paganga G (1996): Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad. Biol. Med. 20, 933-956.
26. Rimm EB, Katan MB, Ascerio A, Stampfer MJ & Willet WC (1996): Relation between intake of flavonoids and risk of coronary heart disease in male health professionals. Ann. Intern. Med. 125, 384-389.
27. Sheriff DS & Fakhri ME (1988): Tea consumption and serum lipids in a Libyan population in Benghazi. Ann. Clin. Biochem. 25, 670-672.
28. Steinberg D, Parthasarathy S, Carew TE, Khoo JC & Witztum JL (1989): Beyond cholesterol. New England J. Med. 320, 915-924.
29. Takahama U (1985): Inhibition of lipoxygenase-dependent lipid peroxidation by quercetin: mechanism of antioxidative function. Phytochemistry 24, 1443-1446.
30. Whitehead TP, Thorpe GHG, Maxwell SRJ (1992): Enhanced Chemiluminescent Assay for Antioxidant Capacity in Biological Fluids. Anal. Chem. 266, 265-277.